TP53 and metabolic dysfunction-associated steatohepatitis: Taken together, these findings suggest that OCA potently suppresses metabolic stress-induced p53 stability and/or ROS production in hepatocytes, thereby inhibiting p53 activation and hepatocyte death during the development of NASH in MC4R-KO mice.